Home > CBD > Royal CBD 500mg Drops 10ml
  • Royal CBD 500mg Drops 10ml

  • Royal CBD 500mg Drops 10ml
  • 1 Bottle £40.00
    2 Bottles £69.90
    3 Bottles £98.85
  • CBD is not intended to diagnose, treat, cure or prevent any ailments.
  • CBD (cannabidiol) is an extract from the cannabis or hemp plant that has no psychoactive properties and is classified as a food supplement in the UK. This means it will not produce a “high”. The Government, therefore, has recently decided that it is legal to grow, sell and consume CBD.

    CBD is classed as a food supplement and does not require a prescription in the UK and as such CBD is not intended to diagnose, treat, cure or prevent any ailments.

    Aqua drops contain 500mg of water soluble CBD and CBDA in a 10ml bottle.

    1 Drop = 1mg CBD

    Taken under the tongue (sub-lingually) CBD aqua drops are highly bioavailable. Simply hold the desired amount under the tongue for 1 – 2 minutes before swallowing. The drops can also be added to a drink to make them more palatable.

    We suggest starting with a serving of 5mg - 5 drops - between one and three times per day. This can be increased gradually until you find the preferred amount. Do NOT take more than 200mg per day.

    Aqua drops can be taken with or without food but preferably 20 – 30 minutes after a meal as they may lower your blood sugar.

    It is recommended that you allow at least a 2 hour gap between administering CBD and any medicines prescribed by a doctor.

    BUT please do not exceed the 200mg daily limit.

    You are strongly advised to discuss using CBD with your doctor if you are taking any prescribed medicines.

    Most publications report that CBD is non-toxic and well tolerated with very few unwanted effects. Any effects that have been reported are minor. However, you should be aware of the potential effects listed below:

    CBD may have an impact on liver enzymes which could affect the way in which pharmaceutical drugs are metabolised. This means that if you are taking medicinal products their effectiveness may be decreased or increased. However, this is reported as a potential and has not been verified in clinical trials.

    Dry mouth can occur with CBD but is easily corrected with a glass of water.

    Light headedness, as a result of a small drop in blood pressure, has been known but is normally only caused within a few minutes of inhaling via a vape device and tends to alleviate quite quickly.

    Drowsiness, particularly with high doses of CBD, is the most common effect although still quite rare. If you are affected, then you should not drive or operate machinery.

    Workplace Drug Testing

    A workplace urine or saliva drug test for cannabis looks for THC or its metabolites. White Pharmacy CBD oil from NuMeds contains cannabidiol. It contains little, if any, THC and complies with the regulations that say it must contain no more than 0.2% THC. Therefore, the use of CBD oil should not give rise to a positive THC urine or saliva result if used according to the recommended dosing instructions. However, we advise that if CBD oil is being used, then the condition for which it is being taken should be declared to Occupational Health, as this itself may be a risk in a safety critical environment.

    It is recommended that all products, whether prescribed or purchased over the counter, should be declared at the time of sample collection to aid accurate interpretation of results. Any medicines or supplements that are not relevant to the interpretation of the result should not be identified on the report, so donors can declare these knowing that this information should remain confidential.

    Servings above 200mg

    In daily servings of 300mg or higher it has been reported by two patients with Parkinsonism* that their tremors got worse. This effect was quickly reversed by reducing the dose.

    If you feel drowsy after taking CBD you should not drive or operate machinery.

    No cases of overdose of CBD have been recorded.

    *International Journal of Neuroscience, Vol 30, 1986 – Issue 4